TSLP and Alzheimer disease: Thymic stromal lymphopoietin (TSLP) is known to increase the severity of AD by stimulating CD11c+ myeloid dendritic cells and thus inducing Th2-mediated inflammation [5], downregulating filaggrin expression levels [6], and causing inflammatory response by T cell migration in filaggrin-deficient skin [7].